+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Respiratory Diagnostics - Global Market Trajectory & Analytics

  • ID: 4805372
  • Report
  • May 2020
  • Region: Global
  • 286 pages
  • Global Industry Analysts, Inc
1 of 2
Amid the COVID-19 crisis and the looming economic recession, the Respiratory Diagnostics market worldwide will grow by a projected US$3.2 Billion, during the analysis period, driven by a revised compounded annual growth rate (CAGR) of 6.1%. Tuberculosis, one of the segments analyzed and sized in this study, is forecast to grow at over 5.9% and reach a market size of US$3.9 Billion by the end of the analysis period. An unusual period in history, the coronavirus pandemic has unleashed a series of unprecedented events affecting every industry. The Tuberculosis market will be reset to a new normal which going forward in a post COVID-19 era will be continuously redefined and redesigned. Staying on top of trends and accurate analysis is paramount now more than ever to manage uncertainty, change and continuously adapt to new and evolving market conditions.

As part of the new emerging geographic scenario, the United States is forecast to readjust to a 4.9% CAGR. Within Europe, the region worst hit by the pandemic, Germany will add over US$96.8 Million to the region's size over the next 7 to 8 years. In addition, over US$95.7 Million worth of projected demand in the region will come from Rest of the European markets. In Japan, the Tuberculosis segment will reach a market size of US$171.6 Million by the close of the analysis period. Blamed for the pandemic, significant political and economic challenges confront China. Amid the growing push for decoupling and economic distancing, the changing relationship between China and the rest of the world will influence competition and opportunities in the Respiratory Diagnostics market. Against this backdrop and the changing geopolitical, business and consumer sentiments, the world’s second largest economy will grow at 10% over the next couple of years and add approximately US$841.2 Million in terms of addressable market opportunity. Continuous monitoring for emerging signs of a possible new world order post-COVID-19 crisis is a must for aspiring businesses and their astute leaders seeking to find success in the now changing Respiratory Diagnostics market landscape. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others:

Abbott Laboratories, Alere, Inc, Becton, Dickinson and Company, bioMerieux SA, Bio-Rad Laboratories, Inc, Cosmed Srl, Philips Healthcare, SDI Diagnostics, Seegene, Inc, Thermo Fisher Scientific, Inc.
Note: Product cover images may vary from those shown
2 of 2
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Global Competitor Market Shares
Respiratory Diagnostics Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
TABLE 1: Respiratory Diagnostics Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
TABLE 2: Respiratory Diagnostics Global Retrospective Market Scenario in US$ Million by Region/Country: 2012-2019
TABLE 3: Respiratory Diagnostics Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027
TABLE 4: Tuberculosis (Disease) World Market by Region/Country in US$ Million: 2020 to 2027
TABLE 5: Tuberculosis (Disease) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019
TABLE 6: Tuberculosis (Disease) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027
TABLE 7: Asthma (Disease) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027
TABLE 8: Asthma (Disease) Historic Market Perspective by Region/Country in US$ Million: 2012 to 2019
TABLE 9: Asthma (Disease) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027
TABLE 10: Chronic Obstructive Pulmonary Disease (Disease) Geographic Market Spread Worldwide in US$ Million: 2020 to 2027
TABLE 11: Chronic Obstructive Pulmonary Disease (Disease) Region Wise Breakdown of Global Historic Demand in US$ Million: 2012 to 2019
TABLE 12: Chronic Obstructive Pulmonary Disease (Disease) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
TABLE 13: Other Diseases (Disease) World Market Estimates and Forecasts by Region/Country in US$ Million: 2020 to 2027
TABLE 14: Other Diseases (Disease) Market Historic Review by Region/Country in US$ Million: 2012 to 2019
TABLE 15: Other Diseases (Disease) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027
TABLE 16: Hospital/Clinical Laboratories (End-Use) Worldwide Latent Demand Forecasts in US$ Million by Region/Country: 2020-2027
TABLE 17: Hospital/Clinical Laboratories (End-Use) Global Historic Analysis in US$ Million by Region/Country: 2012-2019
TABLE 18: Hospital/Clinical Laboratories (End-Use) Distribution of Global Sales by Region/Country: 2012 VS 2020 VS 2027
TABLE 19: Physician Offices (End-Use) Sales Estimates and Forecasts in US$ Million by Region/Country for the Years 2020 through 2027
TABLE 20: Physician Offices (End-Use) Analysis of Historic Sales in US$ Million by Region/Country for the Years 2012 to 2019
TABLE 21: Physician Offices (End-Use) Global Market Share Distribution by Region/Country for 2012, 2020, and 2027
TABLE 22: Reference Laboratories (End-Use) Global Opportunity Assessment in US$ Million by Region/Country: 2020-2027
TABLE 23: Reference Laboratories (End-Use) Historic Sales Analysis in US$ Million by Region/Country: 2012-2019
TABLE 24: Reference Laboratories (End-Use) Percentage Share Breakdown of Global Sales by Region/Country: 2012 VS 2020 VS 2027
TABLE 25: Other End-Uses (End-Use) Worldwide Sales in US$ Million by Region/Country: 2020-2027
TABLE 26: Other End-Uses (End-Use) Historic Demand Patterns in US$ Million by Region/Country: 2012-2019
TABLE 27: Other End-Uses (End-Use) Market Share Shift across Key Geographies: 2012 VS 2020 VS 2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
Market Facts & Figures
US Respiratory Diagnostics Market Share (in %) by Company: 2019 & 2025
Market Analytics
TABLE 28: United States Respiratory Diagnostics Market Estimates and Projections in US$ Million by Disease: 2020 to 2027
TABLE 29: Respiratory Diagnostics Market in the United States by Disease: A Historic Review in US$ Million for 2012-2019
TABLE 30: United States Respiratory Diagnostics Market Share Breakdown by Disease: 2012 VS 2020 VS 2027
TABLE 31: United States Respiratory Diagnostics Latent Demand Forecasts in US$ Million by End-Use: 2020 to 2027
TABLE 32: Respiratory Diagnostics Historic Demand Patterns in the United States by End-Use in US$ Million for 2012-2019
TABLE 33: Respiratory Diagnostics Market Share Breakdown in the United States by End-Use: 2012 VS 2020 VS 2027
CANADA
TABLE 34: Canadian Respiratory Diagnostics Market Estimates and Forecasts in US$ Million by Disease: 2020 to 2027
TABLE 35: Canadian Respiratory Diagnostics Historic Market Review by Disease in US$ Million: 2012-2019
TABLE 36: Respiratory Diagnostics Market in Canada: Percentage Share Breakdown of Sales by Disease for 2012, 2020, and 2027
TABLE 37: Canadian Respiratory Diagnostics Market Quantitative Demand Analysis in US$ Million by End-Use: 2020 to 2027
TABLE 38: Respiratory Diagnostics Market in Canada: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2012-2019
TABLE 39: Canadian Respiratory Diagnostics Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
JAPAN
TABLE 40: Japanese Market for Respiratory Diagnostics: Annual Sales Estimates and Projections in US$ Million by Disease for the Period 2020-2027
TABLE 41: Respiratory Diagnostics Market in Japan: Historic Sales Analysis in US$ Million by Disease for the Period 2012-2019
TABLE 42: Japanese Respiratory Diagnostics Market Share Analysis by Disease: 2012 VS 2020 VS 2027
TABLE 43: Japanese Demand Estimates and Forecasts for Respiratory Diagnostics in US$ Million by End-Use: 2020 to 2027
TABLE 44: Japanese Respiratory Diagnostics Market in US$ Million by End-Use: 2012-2019
TABLE 45: Respiratory Diagnostics Market Share Shift in Japan by End-Use: 2012 VS 2020 VS 2027
CHINA
TABLE 46: Chinese Respiratory Diagnostics Market Growth Prospects in US$ Million by Disease for the Period 2020-2027
TABLE 47: Respiratory Diagnostics Historic Market Analysis in China in US$ Million by Disease: 2012-2019
TABLE 48: Chinese Respiratory Diagnostics Market by Disease: Percentage Breakdown of Sales for 2012, 2020, and 2027
TABLE 49: Chinese Demand for Respiratory Diagnostics in US$ Million by End-Use: 2020 to 2027
TABLE 50: Respiratory Diagnostics Market Review in China in US$ Million by End-Use: 2012-2019
TABLE 51: Chinese Respiratory Diagnostics Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027
EUROPE
Market Facts & Figures
European Respiratory Diagnostics Market: Competitor Market Share Scenario (in %) for 2019 & 2025
Market Analytics
TABLE 52: European Respiratory Diagnostics Market Demand Scenario in US$ Million by Region/Country: 2020-2027
TABLE 53: Respiratory Diagnostics Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2012-2019
TABLE 54: European Respiratory Diagnostics Market Share Shift by Region/Country: 2012 VS 2020 VS 2027
TABLE 55: European Respiratory Diagnostics Market Estimates and Forecasts in US$ Million by Disease: 2020-2027
TABLE 56: Respiratory Diagnostics Market in Europe in US$ Million by Disease: A Historic Review for the Period 2012-2019
TABLE 57: European Respiratory Diagnostics Market Share Breakdown by Disease: 2012 VS 2020 VS 2027
TABLE 58: European Respiratory Diagnostics Addressable Market Opportunity in US$ Million by End-Use: 2020-2027
TABLE 59: Respiratory Diagnostics Market in Europe: Summarization of Historic Demand in US$ Million by End-Use for the Period 2012-2019
TABLE 60: European Respiratory Diagnostics Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
FRANCE
TABLE 61: Respiratory Diagnostics Market in France by Disease: Estimates and Projections in US$ Million for the Period 2020-2027
TABLE 62: French Respiratory Diagnostics Historic Market Scenario in US$ Million by Disease: 2012-2019
TABLE 63: French Respiratory Diagnostics Market Share Analysis by Disease: 2012 VS 2020 VS 2027
TABLE 64: Respiratory Diagnostics Quantitative Demand Analysis in France in US$ Million by End-Use: 2020-2027
TABLE 65: French Respiratory Diagnostics Historic Market Review in US$ Million by End-Use: 2012-2019
TABLE 66: French Respiratory Diagnostics Market Share Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and 2027
GERMANY
TABLE 67: Respiratory Diagnostics Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Disease for the Period 2020-2027
TABLE 68: German Respiratory Diagnostics Historic Market Analysis in US$ Million by Disease: 2012-2019
TABLE 69: German Respiratory Diagnostics Market Share Breakdown by Disease: 2012 VS 2020 VS 2027
TABLE 70: Respiratory Diagnostics Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2020-2027
TABLE 71: German Respiratory Diagnostics Market in Retrospect in US$ Million by End-Use: 2012-2019
TABLE 72: Respiratory Diagnostics Market Share Distribution in Germany by End-Use: 2012 VS 2020 VS 2027
ITALY
TABLE 73: Italian Respiratory Diagnostics Market Growth Prospects in US$ Million by Disease for the Period 2020-2027
TABLE 74: Respiratory Diagnostics Historic Market Analysis in Italy in US$ Million by Disease: 2012-2019
TABLE 75: Italian Respiratory Diagnostics Market by Disease: Percentage Breakdown of Sales for 2012, 2020, and 2027
TABLE 76: Italian Demand for Respiratory Diagnostics in US$ Million by End-Use: 2020 to 2027
TABLE 77: Respiratory Diagnostics Market Review in Italy in US$ Million by End-Use: 2012-2019
TABLE 78: Italian Respiratory Diagnostics Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027
UNITED KINGDOM
TABLE 79: United Kingdom Market for Respiratory Diagnostics: Annual Sales Estimates and Projections in US$ Million by Disease for the Period 2020-2027
TABLE 80: Respiratory Diagnostics Market in the United Kingdom: Historic Sales Analysis in US$ Million by Disease for the Period 2012-2019
TABLE 81: United Kingdom Respiratory Diagnostics Market Share Analysis by Disease: 2012 VS 2020 VS 2027
TABLE 82: United Kingdom Demand Estimates and Forecasts for Respiratory Diagnostics in US$ Million by End-Use: 2020 to 2027
TABLE 83: United Kingdom Respiratory Diagnostics Market in US$ Million by End-Use: 2012-2019
TABLE 84: Respiratory Diagnostics Market Share Shift in the United Kingdom by End-Use: 2012 VS 2020 VS 2027
SPAIN
TABLE 85: Spanish Respiratory Diagnostics Market Estimates and Forecasts in US$ Million by Disease: 2020 to 2027
TABLE 86: Spanish Respiratory Diagnostics Historic Market Review by Disease in US$ Million: 2012-2019
TABLE 87: Respiratory Diagnostics Market in Spain: Percentage Share Breakdown of Sales by Disease for 2012, 2020, and 2027
TABLE 88: Spanish Respiratory Diagnostics Market Quantitative Demand Analysis in US$ Million by End-Use: 2020 to 2027
TABLE 89: Respiratory Diagnostics Market in Spain: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2012-2019
TABLE 90: Spanish Respiratory Diagnostics Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
RUSSIA
TABLE 91: Russian Respiratory Diagnostics Market Estimates and Projections in US$ Million by Disease: 2020 to 2027
TABLE 92: Respiratory Diagnostics Market in Russia by Disease: A Historic Review in US$ Million for 2012-2019
TABLE 93: Russian Respiratory Diagnostics Market Share Breakdown by Disease: 2012 VS 2020 VS 2027
TABLE 94: Russian Respiratory Diagnostics Latent Demand Forecasts in US$ Million by End-Use: 2020 to 2027
TABLE 95: Respiratory Diagnostics Historic Demand Patterns in Russia by End-Use in US$ Million for 2012-2019
TABLE 96: Respiratory Diagnostics Market Share Breakdown in Russia by End-Use: 2012 VS 2020 VS 2027
REST OF EUROPE
TABLE 97: Rest of Europe Respiratory Diagnostics Market Estimates and Forecasts in US$ Million by Disease: 2020-2027
TABLE 98: Respiratory Diagnostics Market in Rest of Europe in US$ Million by Disease: A Historic Review for the Period 2012-2019
TABLE 99: Rest of Europe Respiratory Diagnostics Market Share Breakdown by Disease: 2012 VS 2020 VS 2027
TABLE 100: Rest of Europe Respiratory Diagnostics Addressable Market Opportunity in US$ Million by End-Use: 2020-2027
TABLE 101: Respiratory Diagnostics Market in Rest of Europe: Summarization of Historic Demand in US$ Million by End-Use for the Period 2012-2019
TABLE 102: Rest of Europe Respiratory Diagnostics Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
ASIA-PACIFIC
TABLE 103: Asia-Pacific Respiratory Diagnostics Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
TABLE 104: Respiratory Diagnostics Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2012-2019
TABLE 105: Asia-Pacific Respiratory Diagnostics Market Share Analysis by Region/Country: 2012 VS 2020 VS 2027
TABLE 106: Respiratory Diagnostics Market in Asia-Pacific by Disease: Estimates and Projections in US$ Million for the Period 2020-2027
TABLE 107: Asia-Pacific Respiratory Diagnostics Historic Market Scenario in US$ Million by Disease: 2012-2019
TABLE 108: Asia-Pacific Respiratory Diagnostics Market Share Analysis by Disease: 2012 VS 2020 VS 2027
TABLE 109: Respiratory Diagnostics Quantitative Demand Analysis in Asia-Pacific in US$ Million by End-Use: 2020-2027
TABLE 110: Asia-Pacific Respiratory Diagnostics Historic Market Review in US$ Million by End-Use: 2012-2019
TABLE 111: Asia-Pacific Respiratory Diagnostics Market Share Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and 2027
AUSTRALIA
TABLE 112: Respiratory Diagnostics Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Disease for the Period 2020-2027
TABLE 113: Australian Respiratory Diagnostics Historic Market Analysis in US$ Million by Disease: 2012-2019
TABLE 114: Australian Respiratory Diagnostics Market Share Breakdown by Disease: 2012 VS 2020 VS 2027
TABLE 115: Respiratory Diagnostics Market in Australia: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2020-2027
TABLE 116: Australian Respiratory Diagnostics Market in Retrospect in US$ Million by End-Use: 2012-2019
TABLE 117: Respiratory Diagnostics Market Share Distribution in Australia by End-Use: 2012 VS 2020 VS 2027
INDIA
TABLE 118: Indian Respiratory Diagnostics Market Estimates and Forecasts in US$ Million by Disease: 2020 to 2027
TABLE 119: Indian Respiratory Diagnostics Historic Market Review by Disease in US$ Million: 2012-2019
TABLE 120: Respiratory Diagnostics Market in India: Percentage Share Breakdown of Sales by Disease for 2012, 2020, and 2027
TABLE 121: Indian Respiratory Diagnostics Market Quantitative Demand Analysis in US$ Million by End-Use: 2020 to 2027
TABLE 122: Respiratory Diagnostics Market in India: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2012-2019
TABLE 123: Indian Respiratory Diagnostics Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
SOUTH KOREA
TABLE 124: Respiratory Diagnostics Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Disease for the Period 2020-2027
TABLE 125: South Korean Respiratory Diagnostics Historic Market Analysis in US$ Million by Disease: 2012-2019
TABLE 126: Respiratory Diagnostics Market Share Distribution in South Korea by Disease: 2012 VS 2020 VS 2027
TABLE 127: Respiratory Diagnostics Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by End-Use for the Period 2020-2027
TABLE 128: South Korean Respiratory Diagnostics Historic Market Analysis in US$ Million by End-Use: 2012-2019
TABLE 129: Respiratory Diagnostics Market Share Distribution in South Korea by End-Use: 2012 VS 2020 VS 2027
REST OF ASIA-PACIFIC
TABLE 130: Rest of Asia-Pacific Market for Respiratory Diagnostics: Annual Sales Estimates and Projections in US$ Million by Disease for the Period 2020-2027
TABLE 131: Respiratory Diagnostics Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Disease for the Period 2012-2019
TABLE 132: Rest of Asia-Pacific Respiratory Diagnostics Market Share Analysis by Disease: 2012 VS 2020 VS 2027
TABLE 133: Rest of Asia-Pacific Demand Estimates and Forecasts for Respiratory Diagnostics in US$ Million by End-Use: 2020 to 2027
TABLE 134: Rest of Asia-Pacific Respiratory Diagnostics Market in US$ Million by End-Use: 2012-2019
TABLE 135: Respiratory Diagnostics Market Share Shift in Rest of Asia-Pacific by End-Use: 2012 VS 2020 VS 2027
LATIN AMERICA
TABLE 136: Latin American Respiratory Diagnostics Market Trends by Region/Country in US$ Million: 2020-2027
TABLE 137: Respiratory Diagnostics Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2012-2019
TABLE 138: Latin American Respiratory Diagnostics Market Percentage Breakdown of Sales by Region/Country: 2012, 2020, and 2027
TABLE 139: Latin American Respiratory Diagnostics Market Growth Prospects in US$ Million by Disease for the Period 2020-2027
TABLE 140: Respiratory Diagnostics Historic Market Analysis in Latin America in US$ Million by Disease: 2012-2019
TABLE 141: Latin American Respiratory Diagnostics Market by Disease: Percentage Breakdown of Sales for 2012, 2020, and 2027
TABLE 142: Latin American Demand for Respiratory Diagnostics in US$ Million by End-Use: 2020 to 2027
TABLE 143: Respiratory Diagnostics Market Review in Latin America in US$ Million by End-Use: 2012-2019
TABLE 144: Latin American Respiratory Diagnostics Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027
ARGENTINA
TABLE 145: Argentinean Respiratory Diagnostics Market Estimates and Forecasts in US$ Million by Disease: 2020-2027
TABLE 146: Respiratory Diagnostics Market in Argentina in US$ Million by Disease: A Historic Review for the Period 2012-2019
TABLE 147: Argentinean Respiratory Diagnostics Market Share Breakdown by Disease: 2012 VS 2020 VS 2027
TABLE 148: Argentinean Respiratory Diagnostics Addressable Market Opportunity in US$ Million by End-Use: 2020-2027
TABLE 149: Respiratory Diagnostics Market in Argentina: Summarization of Historic Demand in US$ Million by End-Use for the Period 2012-2019
TABLE 150: Argentinean Respiratory Diagnostics Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
BRAZIL
TABLE 151: Respiratory Diagnostics Market in Brazil by Disease: Estimates and Projections in US$ Million for the Period 2020-2027
TABLE 152: Brazilian Respiratory Diagnostics Historic Market Scenario in US$ Million by Disease: 2012-2019
TABLE 153: Brazilian Respiratory Diagnostics Market Share Analysis by Disease: 2012 VS 2020 VS 2027
TABLE 154: Respiratory Diagnostics Quantitative Demand Analysis in Brazil in US$ Million by End-Use: 2020-2027
TABLE 155: Brazilian Respiratory Diagnostics Historic Market Review in US$ Million by End-Use: 2012-2019
TABLE 156: Brazilian Respiratory Diagnostics Market Share Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and 2027
MEXICO
TABLE 157: Respiratory Diagnostics Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Disease for the Period 2020-2027
TABLE 158: Mexican Respiratory Diagnostics Historic Market Analysis in US$ Million by Disease: 2012-2019
TABLE 159: Mexican Respiratory Diagnostics Market Share Breakdown by Disease: 2012 VS 2020 VS 2027
TABLE 160: Respiratory Diagnostics Market in Mexico: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2020-2027
TABLE 161: Mexican Respiratory Diagnostics Market in Retrospect in US$ Million by End-Use: 2012-2019
TABLE 162: Respiratory Diagnostics Market Share Distribution in Mexico by End-Use: 2012 VS 2020 VS 2027
REST OF LATIN AMERICA
TABLE 163: Rest of Latin America Respiratory Diagnostics Market Estimates and Projections in US$ Million by Disease: 2020 to 2027
TABLE 164: Respiratory Diagnostics Market in Rest of Latin America by Disease: A Historic Review in US$ Million for 2012-2019
TABLE 165: Rest of Latin America Respiratory Diagnostics Market Share Breakdown by Disease: 2012 VS 2020 VS 2027
TABLE 166: Rest of Latin America Respiratory Diagnostics Latent Demand Forecasts in US$ Million by End-Use: 2020 to 2027
TABLE 167: Respiratory Diagnostics Historic Demand Patterns in Rest of Latin America by End-Use in US$ Million for 2012-2019
TABLE 168: Respiratory Diagnostics Market Share Breakdown in Rest of Latin America by End-Use: 2012 VS 2020 VS 2027
MIDDLE EAST
TABLE 169: The Middle East Respiratory Diagnostics Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
TABLE 170: Respiratory Diagnostics Market in the Middle East by Region/Country in US$ Million: 2012-2019
TABLE 171: The Middle East Respiratory Diagnostics Market Share Breakdown by Region/Country: 2012, 2020, and 2027
TABLE 172: The Middle East Respiratory Diagnostics Market Estimates and Forecasts in US$ Million by Disease: 2020 to 2027
TABLE 173: The Middle East Respiratory Diagnostics Historic Market by Disease in US$ Million: 2012-2019
TABLE 174: Respiratory Diagnostics Market in the Middle East: Percentage Share Breakdown of Sales by Disease for 2012,2020, and 2027
TABLE 175: The Middle East Respiratory Diagnostics Market Quantitative Demand Analysis in US$ Million by End-Use: 2020 to 2027
TABLE 176: Respiratory Diagnostics Market in the Middle East: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2012-2019
TABLE 177: The Middle East Respiratory Diagnostics Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
IRAN
TABLE 178: Iranian Market for Respiratory Diagnostics: Annual Sales Estimates and Projections in US$ Million by Disease for the Period 2020-2027
TABLE 179: Respiratory Diagnostics Market in Iran: Historic Sales Analysis in US$ Million by Disease for the Period 2012-2019
TABLE 180: Iranian Respiratory Diagnostics Market Share Analysis by Disease: 2012 VS 2020 VS 2027
TABLE 181: Iranian Demand Estimates and Forecasts for Respiratory Diagnostics in US$ Million by End-Use: 2020 to 2027
TABLE 182: Iranian Respiratory Diagnostics Market in US$ Million by End-Use: 2012-2019
TABLE 183: Respiratory Diagnostics Market Share Shift in Iran by End-Use: 2012 VS 2020 VS 2027
ISRAEL
TABLE 184: Israeli Respiratory Diagnostics Market Estimates and Forecasts in US$ Million by Disease: 2020-2027
TABLE 185: Respiratory Diagnostics Market in Israel in US$ Million by Disease: A Historic Review for the Period 2012-2019
TABLE 186: Israeli Respiratory Diagnostics Market Share Breakdown by Disease: 2012 VS 2020 VS 2027
TABLE 187: Israeli Respiratory Diagnostics Addressable Market Opportunity in US$ Million by End-Use: 2020-2027
TABLE 188: Respiratory Diagnostics Market in Israel: Summarization of Historic Demand in US$ Million by End-Use for the Period 2012-2019
TABLE 189: Israeli Respiratory Diagnostics Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
SAUDI ARABIA
TABLE 190: Saudi Arabian Respiratory Diagnostics Market Growth Prospects in US$ Million by Disease for the Period 2020-2027
TABLE 191: Respiratory Diagnostics Historic Market Analysis in Saudi Arabia in US$ Million by Disease: 2012-2019
TABLE 192: Saudi Arabian Respiratory Diagnostics Market by Disease: Percentage Breakdown of Sales for 2012, 2020, and 2027
TABLE 193: Saudi Arabian Demand for Respiratory Diagnostics in US$ Million by End-Use: 2020 to 2027
TABLE 194: Respiratory Diagnostics Market Review in Saudi Arabia in US$ Million by End-Use: 2012-2019
TABLE 195: Saudi Arabian Respiratory Diagnostics Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027
UNITED ARAB EMIRATES
TABLE 196: Respiratory Diagnostics Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Disease for the Period 2020-2027
TABLE 197: United Arab Emirates Respiratory Diagnostics Historic Market Analysis in US$ Million by Disease: 2012-2019
TABLE 198: Respiratory Diagnostics Market Share Distribution in United Arab Emirates by Disease: 2012 VS 2020 VS 2027
TABLE 199: Respiratory Diagnostics Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by End-Use for the Period 2020-2027
TABLE 200: United Arab Emirates Respiratory Diagnostics Historic Market Analysis in US$ Million by End-Use: 2012-2019
TABLE 201: Respiratory Diagnostics Market Share Distribution in United Arab Emirates by End-Use: 2012 VS 2020 VS 2027
REST OF MIDDLE EAST
TABLE 202: Respiratory Diagnostics Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Disease for the Period 2020-2027
TABLE 203: Rest of Middle East Respiratory Diagnostics Historic Market Analysis in US$ Million by Disease: 2012-2019
TABLE 204: Rest of Middle East Respiratory Diagnostics Market Share Breakdown by Disease: 2012 VS 2020 VS 2027
TABLE 205: Respiratory Diagnostics Market in Rest of Middle East: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2020-2027
TABLE 206: Rest of Middle East Respiratory Diagnostics Market in Retrospect in US$ Million by End-Use: 2012-2019
TABLE 207: Respiratory Diagnostics Market Share Distribution in Rest of Middle East by End-Use: 2012 VS 2020 VS 2027
AFRICA
TABLE 208: African Respiratory Diagnostics Market Estimates and Projections in US$ Million by Disease: 2020 to 2027
TABLE 209: Respiratory Diagnostics Market in Africa by Disease: A Historic Review in US$ Million for 2012-2019
TABLE 210: African Respiratory Diagnostics Market Share Breakdown by Disease: 2012 VS 2020 VS 2027
TABLE 211: African Respiratory Diagnostics Latent Demand Forecasts in US$ Million by End-Use: 2020 to 2027
TABLE 212: Respiratory Diagnostics Historic Demand Patterns in Africa by End-Use in US$ Million for 2012-2019
TABLE 213: Respiratory Diagnostics Market Share Breakdown in Africa by End-Use: 2012 VS 2020 VS 2027

IV. COMPETITION
Total Companies Profiled: 43
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll